News and Announcements
Leaf Resources (ASX: LER) Develops First Facility in Malaysia
- Published July 10, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Leaf Resources (ASX:LER) has announced how the company is following progress on potential second generation sugar projects, within Malaysia enabled by Leaf’s Glycell™ process.
KEY TAKEAWAYS:
Sarawak
- The potential project remains an attractive option for Leaf Resources, with the size and scale of the possible project means that planning and decision making is expected within the next few months.
Johor
- Major advantages of Johor are: accelerated pathway, established pathway of palm oil waster, potential offtake customers within the park.
Biomass
- The Johor bio-park has an existing supply chain of empty fruit bunch (EFB).
Utilities
- The Johor bio-park provides steam, chilled water, and anaerobic digestion for all park tenants and these central utilities are already in place.
Finance
- The company has analysed many financing options for the developments in Sarawak and Johor.
EPC contractor
- Discussions continue with EPC contractors that possess the necessary credentials and experience in the bio-economy.
Bio Nexus Status
- Leaf Development has lodged an application for Bio-Nexus status though a wholly owned subsidiary of Leaf Development, Leaf Malaysia OpCo Sdn Bhd.
Leaf Resources continues to make advancements into the development of its first commercial scale facility in Malaysia, including now a site in Johor offering potential engineering and construction advantages.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
